Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.

University of Regensburg60 enrolled

Overview

It was the aim of the present study to prospectively compare the functional and morphological outcome of idiopathic epiretinal membrane surgery with and without the assistance of Indocyanine green (ICG). The main outcome measure was improvement of best-corrected visual acuity (BCVA). This was treated as an open question and we had no hypothesis which of the two therapies was superior.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Idiopathic Epiretinal Membrane, Cataract

Interventions

Surgery with and without the aid of Indocyanine Green (ICG)DRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with IEM and cataract or posterior chamber intraocular lens pseudophakia complaining of loss of visual acuity and metamorphopsia during the past six months. Exclusion Criteria: * Other retinal disease, non-idiopathic epiretinal membrane, glaucoma or history of retinal detachment.

Locations (1)

Dept. of Ophthalmology, University of Regensburg

Regensburg, Germany

Outcomes

Primary Outcomes

The main outcome measure was improvement of best-corrected visual acuity (BCVA).

Secondary Outcomes

Other outcome measures included postoperative BCVA, status of Amsler grid test, reduction of macular retinal thickness, residual or recurrent macular epiretinal membrane

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.